Showing results (1221-1230 of 6,326) with videos related to
Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|July 2, 2024
Early reduction in albuminuria is associated with a steeper 'dip' in initial estimated glomerular filtration rate but favourable long-term kidney outcomes in people with diabetes receiving sodium-glucose cotransporter-2 inhibitorsYi-Wei Kao, Kun-Chi Yen, Shao-Wei Chen, et al.Diabetes, Obesity & Metabolism|July 3, 2024
Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitusDan Zhang, Jianan Zhu, Nicolai J Wewer Albrechtsen, et al.Diabetes, Obesity & Metabolism|July 3, 2024
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035Yuhan Chen, Li Ma, Zhigang Han, et al.Diabetes, Obesity & Metabolism|July 4, 2024
Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trialPiaopiao Li, Hamed Kianmehr, Dawei Guan, et al.Diabetes, Obesity & Metabolism|July 23, 2024
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matchingHideyuki Iwamoto, Tomohiko Kimura, Yoshiro Fushimi, et al.Diabetes, Obesity & Metabolism|July 26, 2024
Cost-effectiveness analysis of a digital diabetes-prevention programme versus an in-person diabetes-prevention programme in people with prediabetes in the United StatesSooyeol Park, Jeromie Ballreich, Trevor Ward, et al.Diabetes, Obesity & Metabolism|July 18, 2024
Impact of non-alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi-cohort longitudinal studyLijun Zhao, Qingyue Zeng, Xiaoqin Zhou, et al.Diabetes, Obesity & Metabolism|July 18, 2024
Clinical factors influencing the success rate of radioiodine treatment for Graves' diseaseMeiwen He, Limeng Pan, Yifan Li, et al.Diabetes, Obesity & Metabolism|June 14, 2024
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory studyXiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, et al.Diabetes, Obesity & Metabolism|June 10, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world studyRaffaele Napoli, Antonio Nicolucci, Monica Larosa, et al.Pageof 633